b braun 5% glucose intravenous infusion bp 100 ml bottle
b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as solvents for intravenously administered drugs where compatibility has been established.
b braun glucose 5% injection
b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as a solvent for intravenously administered drugs where compatibility has been established.
b braun glucose 5% injection
b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as a solvent for intravenously administered drugs where compatibility has been established.
physioneal 35 glucose 1.36% w/v / 13.6 mg/ml clear-flex,solution for peritoneal dialysis
baxter holding b.v. - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium (s)-lactate solution; sodium bicarbonate - solution for peritoneal dialysis - 1.36 percent weight/volume - hypertonic solutions
physioneal 35 glucose 2.27% w/v / 22.7 mg/ml clear-flex,solution for peritoneal dialysis
baxter holding b.v. - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium (s)-lactate solution; sodium bicarbonate - solution for peritoneal dialysis - 22.7 micromole(s) - hypertonic solutions
physioneal 35 glucose 3.86% w/v / 38.6 mg/ml clear-flex,solution for peritoneal dialysis
baxter holding b.v. - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium (s)-lactate solution; sodium bicarbonate - solution for peritoneal dialysis - 3.86 percent weight/volume - hypertonic solutions
physioneal 40 glucose 1.36% w/v / 13.6 mg/ml clear-flex,solution for peritoneal dialysis
baxter holding b.v. - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium (s)-lactate solution; sodium bicarbonate - solution for peritoneal dialysis - 1.36 percent weight/volume - hypertonic solutions
physioneal 40 glucose 2.27% w/v / 22.7 mg/ml clear-flex,solution for peritoneal dialysis
baxter holding b.v. - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium (s)-lactate solution; sodium bicarbonate - solution for peritoneal dialysis - 2.27 percent weight/volume - hypertonic solutions
physioneal 40 glucose 3.86% w/v / 38.6 mg/ml clear-flex,solution for peritoneal dialysis
baxter holding b.v. - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium (s)-lactate solution; sodium bicarbonate - solution for peritoneal dialysis - 3.86 percent weight/volume - hypertonic solutions
glucose 10% w/v
fresenius kabi new zealand limited - glucose monohydrate 110 g/l equivalent to glucose 100 g/l; - solution for infusion - 100 g/l - active: glucose monohydrate 110 g/l equivalent to glucose 100 g/l excipient: hydrochloric acid sodium hydroxide water for injection - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used. b) gastrointestinal absorption of protein is impaired. c) metabolic requirements for protein are substantially increased, as with extensive burns.